Weekly News Recap #Phispers
FDA refuses to review Moderna’s mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion
The US Food and Drug Administration (FDA) has said it will not review Moderna’s application for its experimental influenz...
Impressions : 1827
Pfizer inks US$ 6 bn oncology deal with China’s 3SBio; BioNTech to invest US$ 1.3 bn in UK for new R&D, AI centers
In news this week, Pfizer announced a US$ 6 billion licensing agreement with China’s 3SBio, securing global rights to a p...
Impressions : 879

